Comparative efficacy of neuroprotective agents for improving neurological function and prognosis in acute ischemic stroke: a network meta-analysis [PDF]
Frontiers in NeuroscienceBackgroundIschemic stroke is the second leading cause of death and the third leading cause of combined disability and mortality globally. While reperfusion therapies play a critical role in the management of acute ischemic stroke (AIS), their ...
Yuchen Wang +6 more
doaj +2 more sources
2024 international conference on neuroprotective agents conference proceedings [PDF]
Experimental Biology and MedicineWilliam Slikker +3 more
doaj +2 more sources
Terazosin Analogs Targeting Pgk1 as Neuroprotective Agents: Design, Synthesis, and Evaluation. [PDF]
Front Chem, 2022 Wang Y, Qian S, Zhao F, Wang Y, Li J.
europepmc +2 more sources
Therapeutic potential of agmatine in the experimental autoimmune encephalomyelitis [PDF]
Vojnosanitetski Pregled, 2021 Background/Aim. Experimental autoimmune encephalomyelitis (EAE) is a model of multiple sclerosis (MS), in which we investigated the neuroprotective effect of agmatine (AGM), known as a primary amine produced via the decarboxylation of L-arginine. Methods.
Stevanović Ivana +4 more
doaj +1 more source
Exploration of Neuroprotective Therapy, 2023 Acute ischemic stroke (AIS) is the leading cause of disability and one of the top causes of mortality worldwide. The current standard of care is reperfusion therapy including intravenous thrombolysis (IVT) and thrombectomy. However, these treatments have
Grace YY Chia +5 more
doaj +1 more source
The Antioxidative Effects of Picein and Its Neuroprotective Potential: A Review of the Literature
Molecules, 2022 Neurodegenerative diseases (NDDs) are the main cause of dementia in the elderly, having no cure to date, as the currently available therapies focus on symptom remission.
Leila Elyasi +3 more
doaj +1 more source
Graph theoretical network analysis, in silico exploration, and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against α-synuclein [PDF]
BioImpacts, 2022 Introduction: Parkinson's disease (PD) is a chronic, devastating neurodegenerative disorder marked by the death of dopaminergic neurons in the midbrain's substantia nigra pars compacta (Snpc). In alpha-synuclein (α-Syn) self-aggregation, the existence of
Raja Rajeswari Rajeshkumar +9 more
doaj +1 more source
Neuroprotective Agents With Reperfusion Therapies in Ischemic Stroke: Evidence From Recent Randomized Trials. [PDF]
CureusWesley MJ +10 more
europepmc +3 more sources
Antidotal and protective effects of mangosteen (Garcinia mangostana) against natural and chemical toxicities: A review [PDF]
Iranian Journal of Basic Medical Sciences, 2023 Chemical and natural toxic compounds can harm human health through a variety of mechanisms. Nowadays, herbal therapy is widely accepted as a safe method of treating toxicity.
Aidin Mohammadi Zonouz +2 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Background: Renin-angiotensin system (RAS) inhibitors have been suggested as protective agents in Parkinson’s disease (PD). However, epidemiological evidence on the association between RAS inhibitors and the development of PD is inconsistent.Objectives ...
Youngkwon Jo +6 more
doaj +1 more source